title: [A use of betaserc in ataxic syndromes].
abstract: Thirty-five patients with vestibular (25) and cerebellar (10) ataxy were medicated by betacerc during 21 days. A status of balance function was estimated, using stabilometric complex MBN "Biomechanika", before and after the treatment course. After the end of the treatment, symptoms of static ataxy and vertigo were reduced. An analysis of stabilogramm has confirmed a tendency to normalization of static balance parameters as a result of betacerc treatment of vestibular and cerebella types of ataxy, with significant decrease of general length of the way, area of support and velocity of gravity center displacement.
authors.forename: S V
authors.initials: SV
authors.lastname: Prokopenko
authors.forename: V A
authors.initials: VA
authors.lastname: Rudnev
authors.forename: E V
authors.initials: EV
authors.lastname: Afanas'eva
authors.forename: V G
authors.initials: VG
authors.lastname: Abramov
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001259:Ataxia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D001621:Betahistine / Q000008:administration & dosage / Q000627:therapeutic use*; D002524:Cerebellar Ataxia / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D017442:Histamine Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013577:Syndrome; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014717:Vertigo / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D017442:Histamine Agonists; D014665:Vasodilator Agents; D001621:Betahistine